Article info
PDFEditors’ commentary
Highlights from this issue
Citation
Highlights from this issue
Publication history
- Accepted December 16, 2020
- First published January 19, 2021.
Online issue publication
January 19, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases
- Mitochondrial neurogastrointestinal encephalopathy disease (MNGIE)
- The unfolding clinical spectrum of POLG mutations
- Mitochondrial disease: mimics and chameleons
- SANDO syndrome in a cohort of 107 patients with CPEO and mitochondrial DNA deletions
- Rare pathogenic mutation in the thymidine phosphorylase gene (TYMP) causing mitochondrial neurogastrointestinal encephalomyelopathy
- Recognition, investigation and management of mitochondrial disease
- A young man with bilateral epilepsia intractable and partialis continua
- Distal myopathy with cachexia: an unrecognised phenotype caused by dominantly-inherited mitochondrial polymerase γ mutations
- Frequency of mitochondrial transfer RNA mutations and deletions in 225 patients presenting with respiratory chain deficiencies